GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tristel PLC (FRA:R1V) » Definitions » Research & Development

Tristel (FRA:R1V) Research & Development : €0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Tristel Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Tristel's Research & Development for the six months ended in Dec. 2024 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Tristel Research & Development Historical Data

The historical data trend for Tristel's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tristel Research & Development Chart

Tristel Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tristel Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tristel Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tristel  (FRA:R1V) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Tristel Research & Development Related Terms

Thank you for viewing the detailed overview of Tristel's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Tristel Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tristel PLC (FRA:R1V) » Definitions » Research & Development
Comparable Companies
LSE:BVC LSE:SPEC LSE:CNSL LSE:AMS ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM COO BAX WST HOLX ALGN NZSE:FPH
Traded in Other Exchanges
TSTL:UK
Address
Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY
Website
https://www.tristel.com
Tristel PLC is a player in the healthcare platform. The company is a manufacturer of chlorine dioxide chemistry used for the decontamination of medical devices. Its operating segments include three sectors, Hospital medical device decontamination products which are used predominantly for infection control in hospitals; manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from Hospital medical device decontamination.

Tristel Headlines

No Headlines